Capsules represent 39.0% of form demand, microbial accounts for 36.5% of source sales and gut health holds 38.5% within the health benefit segment in 2026. The fruit enzyme supplements market was valued at USD 661.2 million in 2025 and is forecast to post an 8.9% CAGR between 2026 and 2036.